Targeted Therapies

NEWS – May 23, 2013:
Nordion Enters into Agreement to Divest Targeted Therapies Business to BTG plc

Nordion's Targeted Therapies segment is focused on the targeted treatment of cancer.

Our Targeted Therapies product, TheraSphere®, is used in the treatment of liver cancer by targeting the disease from within the body with a higher concentration of radiation directed to the tumor, thereby limiting both damage to surrounding healthy tissue and side effects for the patient. TheraSphere® is used in the treatment of both inoperable primary and metastatic liver cancer, and has approvals and is reimbursed in certain key markets.


(International Version)

More About TheraSphere: An Innovative Treatment for Liver Cancer